Jacobson Pharma Corporation Limited manufactures pharmaceuticals. The Company researches, produces, and sells a variety of generic and proprietary Chinese medicines around the world.

Notification Letter And Request Form To Non-Registered Shareholders

Notification Letter And Reply Form To Registered Shareholders

Financial Statements/ESG Information - [Interim/Half-Year Report]

2024/2025 Interim Report

Announcements and Notices - [Dividend or Distribution (Announcement Form)]

Interim Dividend For The Six Months Ended 30 September 2024

Announcements and Notices - [Interim Results / Dividend or Distribution / Closure of Books or Change of Book Closure Period]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Jacobson Pharma (2633 HK)

Notification Letter And Request Form To Non-Registered Shareholders

Notification Letter And Reply Form To Registered Shareholders

2024/2025 Interim Report

Interim Dividend For The Six Months Ended 30 September 2024

Interim Results Announcement For The Six Months Ended 30 September 2024

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)